FDA Approved: LEVETIRACETAM EXTENDED-RELEASE — Supplemental Application (Omnivium Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application to authorize an extended-release formulation of levetiracetam, manufactured by Omnivium Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Levetiracetam Extended-Release (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM EXTENDED-RELEASE (LEVETIRACETAM)